Clinical Trial Update: Fecal Molecular Susceptibility-guided Hp First-line Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating fecal molecular susceptibility-guided first-line therapy for Helicobacter pylori infections; currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infections

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 4 | Status: NOT_YET_RECRUITING